Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to -$39.5 million.

  • Sotera Health's Net Cash Flow fell 16761.68% to -$39.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.4 million, marking a year-over-year decrease of 11686.82%. This contributed to the annual value of -$5.4 million for FY2024, which is 9441.86% up from last year.
  • Per Sotera Health's latest filing, its Net Cash Flow stood at -$39.5 million for Q3 2025, which was down 16761.68% from $19.3 million recorded in Q2 2025.
  • In the past 5 years, Sotera Health's Net Cash Flow registered a high of $262.8 million during Q1 2023, and its lowest value of -$390.4 million during Q2 2023.
  • Over the past 5 years, Sotera Health's median Net Cash Flow value was $14.0 million (recorded in 2022), while the average stood at $10.7 million.
  • In the last 5 years, Sotera Health's Net Cash Flow skyrocketed by 308196.0% in 2022 and then crashed by 187899.85% in 2023.
  • Quarter analysis of 5 years shows Sotera Health's Net Cash Flow stood at -$7.7 million in 2021, then surged by 3081.96% to $229.4 million in 2022, then plummeted by 80.6% to $44.5 million in 2023, then tumbled by 137.53% to -$16.7 million in 2024, then plummeted by 136.63% to -$39.5 million in 2025.
  • Its last three reported values are -$39.5 million in Q3 2025, $19.3 million for Q2 2025, and $27.6 million during Q1 2025.